Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review

Front Pediatr. 2022 May 23:10:829927. doi: 10.3389/fped.2022.829927. eCollection 2022.

Abstract

Aggressive natural killer cell leukemia (ANKL) is a rare malignant tumor, especially uncommon in children. ANKL has very aggressive clinical course and bad prognosis and is usually caused by Epstein-Barr virus infection. ANKL often has clinical manifestations of hemophagocytic lymphohistiocytosis (HLH) and can be easily treated as HLH, which might complicate this aggressive disease. Here we report an ANKL in adolescent whose clinical presentation was highly aggressive and response to L-asparaginase containing chemotherapy was very bad. Early-onset Flow cytometry of peripheral blood and bone marrow help make the diagnosis.

Keywords: Epstein-Barr virus; aggressive natural killer cell leukemia; case report; children; hemophagocytic lymphohistiocytosis.

Publication types

  • Case Reports